Pfizer announces positive results from phase-III study in 20-valent Pneumococcal Conjugate Vaccine in infants in EU Read more
EMA increases general, non-pharmacovigilance fees by 0.3 per cent and 5.3 per cent from 1st April, 2022 Read more